Lv4
462 积分 2023-12-06 加入
Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study
22小时前
已完结
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial
22小时前
已关闭
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial
22小时前
已完结
A prospective study of neoadjuvant pembrolizumab plus chemotherapy for resectable esophageal squamous cell carcinoma: The Keystone-001 trial
22小时前
已完结
A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors
2个月前
已完结
Early breast cancer
2个月前
已完结
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
2个月前
已完结
Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer
2个月前
已完结
ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
2个月前
已完结
Technical and biological constraints on ctDNA-based genotyping
2个月前
已完结
皖公网安备34019202002308
